Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Research:CAGR of 3.6% during the forecast period

Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Definition

Preoperative Skin Antiseptic Product are medical-grade antiseptic Wash Lotion & Solution, Wipes, Gloves, Caps, etc. specifically to disinfect and cleanse the skin, thereby reducing the presence of harmful microorganisms. These products are widely used in healthcare settings for various purposes, including preoperative skin preparation and routine patient hygiene.





Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Industry View

Preoperative Skin Antiseptic Products are specially formulated for disinfection and cleaning of the skin, which can effectively reduce the presence of harmful microorganisms. They are widely used for preoperative skin preparation and routine patient hygiene. Common product types include solutions, washes, wipes, shampoo caps, brushes, applicators, etc.

Chlorhexidine gluconate has a killing effect on Gram-positive and Gram-negative bacteria, facultative anaerobes, aerobic bacteria and yeasts. It is particularly effective against Gram-positive bacteria. With the advent of an aging population, the number of surgeries worldwide has increased year by year. According to statistics, more than 300 million people undergo surgical operations worldwide each year, and surgical site infections (SSIs) and the wounds they cause are also increasing. It refers to nosocomial infections secondary to surgery that occur at or near the surgical incision, deep organs or cavities. It is one of the serious complications after modern surgery and orthopedics, a common cause of unplanned readmissions, and a global problem. SSI patients account for 2% to 5% of hospitalized surgical patients, and the annual incidence rate varies. The number of SSI patients in the United States is 160,000 to 300,000 per year. Studies have shown that chlorhexidine is more advantageous than povidone-iodine in preventing total infection and superficial site infection after potentially contaminated surgery.

With the outbreak of COVID-19, Preoperative Skin Antiseptic Product ushered in explosive growth in 2020-2021. From a global perspective, Europe and the United States are the core market areas for Preoperative Skin Antiseptic Product, especially North America, which accounts for 43% of the revenue share, followed by Europe, which accounts for 35% of the market share. The Asia-Pacific region currently mainly uses povidone-iodine for preoperative skin disinfection, but with the continuous expansion of awareness of Preoperative Skin Antiseptic Products and the gradual deepening of market promotion, there will be huge market potential in the future.

There are many global players in the Preoperative Skin Antiseptic Product market, with a wide variety of product types, but most of them are small in scale. The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023. Among them, BD's ChloraPrep applicator products are the world's leading sales, with annual sales exceeding 150 million units. Product types have also gradually evolved from the initial solutions and lotions to wet wipes, gloves, brushes, shampoo caps, etc. Currently, lotions and solution products occupy the core market share.

Preoperative Skin Antiseptic Products are widely used for patient skin disinfection to prevent infection, including hospital-acquired infections (HAIs) and surgical site infections (SSIs). With the increase in demand in surgical and preoperative environments and the increasing awareness of infection prevention, the overall market will continue to expand.



Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Market Summary

According to the new market research report "Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Market Report 2024-2030", published by QYResearch, the global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis market size is projected to reach USD 0.78 billion by 2030, at a CAGR of 3.6% during the forecast period.

Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis MarketSize(US$ Million), 2019-2030
250206-165509.webp (26 KB)

Above data is based on report from QYResearch: Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Top20 Players Rankingand Market Share (Ranking is based on the revenue of 2023, continually updated)
250206-165540.webp (35 KB)

Above data is based on report from QYResearch: Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Preoperative Skin Antiseptic Product for Patient Skin Antisepsis include BD, Ecolab, Stryker, Molnlycke, Xttrium, 3M, B. Braun, Medichem, GAMA Healthcare, PDI EMEA Ltd., etc. In 2023, the global top five players had a share approximately 60.0% in terms of revenue.

Preoperative Skin Antiseptic Product for Patient Skin Antisepsis,Global Market Size, Split by Product Segment
250206-165604.webp (30 KB)

Based on or includes research from QYResearch: Global Preoperative Skin Antiseptic Product for Patient Skin Antisepsis Market Report 2024-2030.

In terms of product type, currently Antiseptic Wash Lotion & Solution is the largest segment, hold a share of 54.6%.

In terms of product application, currently Intensive Care Unit is the largest segment, hold a share of 38.82%.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let's work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.